retatrutide clinical trials results The result of the late stage trial is another boost to Eli Lilly's booming obesity business — weight-loss drugs have helped propel the US company to become the first pharmaceuticals group to Retatrutide Explained: How It Works,

Klebanoff: We are studying GLP-1 prior authorization policies across U.S

Caloric absorption and digestion remain normal and routine

Persistent diarrhea that continues for a long time should not be ignored because it may increase the risk of dehydration or nutritional problems

A NOVEL non-peptide glucagon-like peptide-1 receptor agonist (GLP-1) pill is more effective for weight loss than oral semaglutide in patients with Type 2 diabetes, a 2026 Phase III trial has found

Further research is needed to clarify the long-term effects of GLP-1RAs on liver cancer outcomes and their role in cancer prevention in high-risk populations

Operationally, GLP-1 therapies have also increased the administrative burden